| 摘要: |
| 目的 综述选择性环氧化酶-2抑制剂在心血管方面的安全性及其作用机制。方法 通过查阅国内外相关文献,分别比较归纳了不同选择性环氧化酶-2抑制剂引发心血管事件的风险性,并总结了罗非昔布、塞来昔布等对心血管的作用机制。结果 对选择性环氧化酶-2抑制剂引发心血管不良反应的研究进展进行了比较全面的总结。结论 不同选择性环氧化酶-2抑制剂在心血管安全性方面有明显差别,比较几种昔布类药物,塞来昔布相对安全,与小剂量阿司匹林联合服用可降低心血管风险性。 |
| 关键词: 环氧化酶-2 心血管 塞来昔布 罗非昔布 |
| DOI: |
| 基金项目:北京市科委首都市民健康项目培育科研基金资助项目(No.Z12110200750000) |
|
|
|
| Research progress on the effect of selective COX-2 inhibitors on cardiovascular diseases |
| YANG Ying1,SUN Ru2,CAO Yanhua2 |
| (1.No.401 Hospital Affiliated to Chinese People's Liberation Army,Qingdao 266071,China;2.Provincial Hospital affiliated to Shandong University,Jinan 250021,China) |
| Abstract: |
| Objective To review the effect of selective COX-2 inhibitors on cardiovascular diseases and their mechanisms.Methods By consulting related references,the risk of cardiovascular events caused by different selective COX-2 inhibitors was compared, and the effect mechanisms of rofecoxib and celecoxib on cardiovascular system were summarized.Results The research progress of selective COX-2 inhibitors and adverse cardiovascular events were comprehensively summarized.Conclusion A different risk profile for COX-2 inhibitors had emerged.Compared to rofecoxib and other coxibs,celecoxib was relatively safe.Receiving celecoxib with low-dose aspirin was recommended to exhibit lower cardiovascular risk. |
| Key words: COX-2 Cardiovascular disease Celecoxib Rofecoxib |